GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viemed Healthcare Inc (NAS:VMD) » Definitions » GF Value

Viemed Healthcare (Viemed Healthcare) GF Value : $9.59 (As of May. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Viemed Healthcare GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-14), Viemed Healthcare's share price is $6.79. Viemed Healthcare's GF Value is $9.59. Therefore, Viemed Healthcare's Price-to-GF-Value for today is 0.71.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Viemed Healthcare is Modestly Undervalued.


Viemed Healthcare  (NAS:VMD) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Viemed Healthcare's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=6.79/9.59
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viemed Healthcare GF Value Related Terms

Thank you for viewing the detailed overview of Viemed Healthcare's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Viemed Healthcare (Viemed Healthcare) Business Description

Traded in Other Exchanges
Address
625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services.
Executives
Jeremy Trahan officer: Chief Legal Officer 625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Timothy Smokoff director 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Nitin Kaushal director 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Randy E. Dobbs director C/O VIEMED HEALTHCARE, INC, 625 E. KALISTE SALOOM RD, LAFAYETTE LA 70508
Bruce D Greenstein director 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
William Todd Zehnder director, officer: Chief Operating Officer 400 E. KALISTE SALOOM ROAD, SUITE 6000, LAFAYETTE LA 70508
Casey Hoyt director, officer: Chief Executive Officer 625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Michael Moore officer: President 625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Trae Fitzgerald officer: Chief Financial Officer 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
William Frazier director, officer: Chief Medical Officer 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Jerome Cambre officer: Vice President of Sales 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Sabrina Heltz director 625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508
Ewell Patrick Eagan officer: General Counsel 625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508

Viemed Healthcare (Viemed Healthcare) Headlines

From GuruFocus

Viemed Healthcare Announces Date and Time for Conference Call

By GlobeNewswire GlobeNewswire 07-27-2020

Viemed Announces New Senior Secured Credit Facilities

By Value_Insider Value_Insider 11-29-2022

Viemed Announces Strategic Investment in Population Health Sector

By Stock market mentor Stock market mentor 01-12-2023

Viemed Healthcare Announces Date and Time for Conference Call

By GlobeNewswire GlobeNewswire 02-16-2023

Viemed Healthcare Announces Date and Time for Conference Call

By GlobeNewswire GlobeNewswire 07-20-2022

Viemed Healthcare Announces Date and Time for Conference Call

By GlobeNewswire GlobeNewswire 10-20-2022

5 Health Care Stocks Trading with Low Price-Earnings Ratios

By Tiziano Frateschi Tiziano Frateschi 04-21-2021

Viemed Healthcare Announces Date and Time for Conference Call

By Value_Insider Value_Insider 10-20-2022